Precision Medicine Solutions Made Easier and More Affordable to Healthcare Providers

Health Outcomes Sciences offers a new personalized predictive analytics platform that helps reduce variability and improve outcomes

Dr. John Spertus explains how a predictive model is used in the ED for stroke patients.

???pagination.previous??? ???pagination.next???

OVERLAND PARK, Kan.--()--Health Outcomes Sciences (HOS), serving hospitals and health systems across the country, has achieved new milestones in its journey to deliver personalized predictive analytics for cardiovascular patients. As a provider of online healthcare technology solutions, the month of June 2016 marks the company’s release of its patented next generation ePRISM® platform along with brand new subscription plans that make adoption of its precision medicine solutions easier and more affordable.

“We’re seeing a groundswell of interest in the use of predictive analytics to support personalized care and shared decision-making,” says Dr. John Spertus, HOS co-founder and Chief Scientific Officer. “However, we know that cost can be a barrier to rapid adoption, as can the IT burden associated with implementing new technology. That’s why we’ve made it possible for hospitals and health systems to be up and running with our next generation ePRISM® platform in just a few days’ time, and they can use any of the predictive models in our library for just a few hundred dollars a month.”

The company’s new ePRISM® Level 1 and Level 2 options offer hospitals and health systems their own private online web portal along with a subscription to any predictive model in the company’s library. Differences between the two options include the number of user logins, the ability to save data and download it for localized use, and the opportunity for branding with a logo. Both options include no-cost educational webinars and US-based phone support. Although the new ePRISM® Level 1 and Level 2 options reduce the operational requirements of a major IT project, the company will continue to offer a more robust option that fully integrates with all major electronic medical record (EMR) systems.

The company’s partnership with the American College of Cardiology (ACC) has contributed to a strong track record of client success in cardiovascular care. Its suite of predictive models for percutaneous coronary intervention (PCI) and implantable cardioverter defibrillator (ICD) are derived directly from ACC NCDR® research, and are regarded as the gold standard. Within the next few months, the company will expand its library to include suites of predictive models for orthopedics and oncology, expressly in support of CMS initiatives addressing Comprehensive Care for Joint Replacement (CJR) and Screening for Lung Cancer with Low Dose Computed Tomography.

Spertus offers, “Thousands of predictive models have been published in scientific annals, but HOS is careful to select only those that offer high impact to patient outcomes. We work closely with clinical care teams to embed the predictive models seamlessly into routine workflow.”

Earlier this year, HOS added new predictive models to its library with the assistance of Saint Luke’s Health System in Kansas City. Spertus describes in this video how one of the models is being used at Saint Luke’s Hospital as part of the RESOLVE research study, an American Heart Association (AHA) initiative that seeks to improve outcomes for stroke patients. The company worked with Drs. Arnold and Cohen at Saint Luke’s Mid America Heart Institute to launch a model that addresses outcomes for transcatheter aortic valve replacement, or TAVR (otherwise known as transcatheter aortic valve implantation, or TAVI). The company is currently offering TAVR/TAVI teams around the world access to the model via a free online risk calculator.

“Our solutions play a pivotal role in healthcare quality management,” Spertus explains. “The Wall Street Journal recently reported on the prevalence of medical errors, and the toll on lives lost. Personalized precision medicine can help overcome that growing epidemic.”

About Health Outcomes Sciences

Health Outcomes Sciences is propelling the practice of precision medicine through its patented content enablement platform, ePRISM®, which translates scientific models into automated evidence-based decision support solutions. By helping health and life science organizations -- as well as allied technology partners -- deliver the power of personalized predictive science at the point of care, the company facilitates significant and measurable improvements in clinical and financial outcomes, variations in care, appropriate use and rational consumption of resources. The company’s solutions are specialty agnostic, scalable at the enterprise level and employ a cloud-hosted software-as-a-service (SaaS) business model. For additional information on Health Outcomes Sciences, visit www.h-outcomes.com.

Contacts

Health Outcomes Sciences, Inc.
Joy Efron, 801-979-3105
Vice President Commercialization
jefron@h-outcomes.com

Release Summary

Precision medicine solutions are made easier and more affordable through a new predictive analytics platform from Health Outcomes Sciences.

Contacts

Health Outcomes Sciences, Inc.
Joy Efron, 801-979-3105
Vice President Commercialization
jefron@h-outcomes.com